Detailed Information
Cited 6 time in 
Cited 6 time in 
Cited 6 time in
Metadata Downloads
Association of potent P2Y12 blockers with ischemic and bleeding outcomes in non-ST-segment elevation myocardial infarction
- Authors
- Sim, DS[Sim, Doo Sun]; Jeong, MH[Jeong, Myung Ho]; Kim, HS[Kim, Hyo Soo]; Gwon, HC[Gwon, Hyeon Cheol]; Seung, KB[Seung, Ki Bae]; Rha, SW[Rha, Seung Woon]; Chae, SC[Chae, Shung Chull]; Kim, CJ[Kim, Chong Jin]; Cha, KS[Cha, Kwang Soo]; Park, JS[Park, Jong Sun]; Yoon, JH[Yoon, Jung Han]; Chae, JK[Chae, Jei Keon]; Joo, SJ[Joo, Seung Jae]; Choi, DJ[Choi, Dong Ju]; Hur, SH[Hur, Seung Ho]; Seong, IW[Seong, In Whan]; Cho, MC[Cho, Myeong Chan]; Kim, DI[Kim, Doo Il]; Oh, SK[Oh, Seok Kyu]; Ahn, TH[Ahn, Tae Hoon]; Hwang, JY[Hwang, Jin Yong]; KAMIR-NIH Registry Investigators[KAMIR-NIH Registry Investigators]
- Issue Date
- Jan-2019
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- Antiplatelet agents; Drug-eluting stents; Myocardial infarction
- Citation
- JOURNAL OF CARDIOLOGY, v.73, no.1-2, pp.142 - 150
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CARDIOLOGY
- Volume
- 73
- Number
- 1-2
- Start Page
- 142
- End Page
- 150
- ISSN
- 0914-5087
- Abstract
- Background: Potent P2Y12 blockers are preferred in patients with acute non-ST-segment elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention (PCI). However, the risk of bleeding remains a major concern. We assessed the association of potent P2Y12 blockers with ischemic and bleeding outcomes in patients with NSTEMI.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- GWON, HYEON CHEOL
- Medicine (Medicine)